BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 577177)

  • 1. [Dose finding for clinical trials of antiarrhythmic substances (author's transl)].
    Hahn KJ
    Arzneimittelforschung; 1977 Feb; 27(2A):283-5. PubMed ID: 577177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacology of antiarrhythmic drugs: variability of metabolism and dose requirements.
    Follath F
    J Cardiovasc Pharmacol; 1991; 17 Suppl 6():S74-6. PubMed ID: 1723123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlations between plasmatic concentrations and antiarrhythmic effect of bunaphtine (author's transl)].
    Rossi P; Carcano G; Rognoni G; Cernigliaro C; Calcaterra G
    G Ital Cardiol; 1976; 6(6):1048-55. PubMed ID: 1022605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-arrhythmia drugs in geriatric patients].
    Hohnloser SH; Zabel M
    Fortschr Med; 1991 Aug; 109(25):492-5. PubMed ID: 1937335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of antiarrhythmic drugs by sudden death trials.
    Fisher LD
    Circulation; 1986 Feb; 73(2 Pt 2):II98-100. PubMed ID: 3510770
    [No Abstract]   [Full Text] [Related]  

  • 6. [Propafenon therapy of arrhythmias in infancy and childhood (author's transl)].
    Weber H; Eigster G; Wesselhoeft H
    Monatsschr Kinderheilkd; 1981 Jul; 129(7):410-3. PubMed ID: 6167855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Methodology in clinical trials of anti-arrhythmia agents in ventricular arrhythmias. Analysis and perspective following results of the CAST study].
    Jaillon P; Dupuis B
    Arch Mal Coeur Vaiss; 1991 Feb; 84 Spec No 2():35-40. PubMed ID: 1669238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasma levels of anti-arrhythmic drugs and clinical effectiveness in the treatment of ventricular arrhythmias].
    Bracchetti D; Naccarella F; Guaragna RF; Palmieri M; Bartoletti A; Barbato G; Malini PL; Marchesini B; Ambrosioni E
    G Ital Cardiol; 1986 Aug; 16(8):648-59. PubMed ID: 3539687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical application of pharmacokinetics for antiarrhythmic drugs.
    Harrison DC
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():65-72. PubMed ID: 6803703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Flecainide: a new antiarrhythmic agent].
    Leclercq JF; Coumel P
    Arch Mal Coeur Vaiss; 1983 Oct; 76(10):1218-30. PubMed ID: 6418100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Possibilities and limitations of treatment for arrhythmia].
    Lüderitz B
    Z Gesamte Inn Med; 1991 Aug; 46(12):425-30. PubMed ID: 1950023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing geriatric arrhythmias, II: Drug selection and use.
    Lynch RA; Horowitz LN
    Geriatrics; 1991 Apr; 46(4):41-4, 49-52, 54. PubMed ID: 2010094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the assessment of antiarrhythmic drug efficacy by Holter electrocardiography (author's transl)].
    Suzuki Y; Ishizaka K; Kobayashi A; Kamikawa T; Hayashi H; Masumura Y; Yamazaki N
    Nihon Naika Gakkai Zasshi; 1982 Apr; 71(4):421-30. PubMed ID: 7108327
    [No Abstract]   [Full Text] [Related]  

  • 14. [Importance of pharmacokinetic studies in the clinical phase of experimentation with anti-arrhythmia agents].
    Jaillon P
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():57-64. PubMed ID: 6803702
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antiarrhythmic drugs--differences between laboratory and clinical effects].
    Harumi K
    Kokyu To Junkan; 1984 Dec; 32(12):1225-33. PubMed ID: 6396782
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical evaluation of new anti-arrhythmia drugs after the CAST (Cardiac Arrhythmia Suppression Trial) study].
    Meinertz T; Zehender M; Hohnloser SH
    Z Kardiol; 1992; 81 Suppl 4():145-9. PubMed ID: 1290291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-arrhythmia treatment (clinical problems, classification of anti-arrhythmia drugs and personal experience].
    Walczak F
    Kardiol Pol; 1992; 36(2):97-104. PubMed ID: 1583833
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical approach to antiarrhythmic therapy in patients with ventricular arrhythmia.
    Reddy CP; Arnett JD
    J La State Med Soc; 1989 May; 141(5):45-8. PubMed ID: 2659710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic therapy for ventricular arrhythmias.
    Zimmermann M
    J Cardiovasc Pharmacol; 1991; 17 Suppl 6():S59-64. PubMed ID: 1723121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of long-acting antiarrhythmic agents and the combinations in the treatment of cardiovascular diseases].
    Takagaki K; Ohe T
    Kokyu To Junkan; 1990 Nov; 38(11):1073-9. PubMed ID: 2263767
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.